{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:12:01Z","timestamp":1739855521516,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,17]]},"DOI":"10.7759\/cureus.79164","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T14:51:31Z","timestamp":1739803891000},"source":"Crossref","is-referenced-by-count":0,"title":["Progressive Muscle Weakness: Identifying Necrotizing Autoimmune Myopathy as a Rare Culprit"],"prefix":"10.7759","author":[{"given":"Bojan","family":"Miletic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Schneiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavroula","family":"Lygkoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2022.114108","article-title":"Statin-induced necrotizing autoimmune myopathy: a systematic review","volume":"60","author":"Somagutta MK","year":"2022","unstructured":"Somagutta MK, Shama N, Pormento MK, et al.. Statin-induced necrotizing autoimmune myopathy: a systematic review. Reumatologia. 2022, 60:63-9. 10.5114\/reum.2022.114108","journal-title":"Reumatologia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2019.12.019","article-title":"Statin-induced necrotizing autoimmune myopathy","volume":"2","author":"Gawey B","year":"2020","unstructured":"Gawey B, Tannu M, Rim J, Sperling L, Henry TL. Statin-induced necrotizing autoimmune myopathy. JACC Case Rep. 2020, 2:440-3. 10.1016\/j.jaccas.2019.12.019","journal-title":"JACC Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/21501327211028714","article-title":"Statin-induced autoimmune necrotizing myopathy","volume":"12","author":"Jayatilaka S","year":"2021","unstructured":"Jayatilaka S, Desai K, Rijal S, Zimmerman D. Statin-induced autoimmune necrotizing myopathy. J Prim Care Community Health. 2021, 12:21501327211028714. 10.1177\/21501327211028714","journal-title":"J Prim Care Community Health"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2013.09.023","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update","volume":"29","author":"Mancini GB","year":"2013","unstructured":"Mancini GB, Tashakkor AY, Baker S, et al.. Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Working Group Consensus update. Can J Cardiol. 2013, 29:1553-68. 10.1016\/j.cjca.2013.09.023","journal-title":"Can J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy--a genomewide study","volume":"359","author":"Link E","year":"2008","unstructured":"Link E, Parish S, Armitage J, et al.. SLCO1B1 variants and statin-induced myopathy--a genomewide study. N Engl J Med. 2008, 359:789-99. 10.1056\/NEJMoa0801936","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000497","article-title":"Statin-associated autoimmune myopathy: a systematic review of 100 cases","volume":"23","author":"Nazir S","year":"2017","unstructured":"Nazir S, Lohani S, Tachamo N, Poudel D, Donato A. Statin-associated autoimmune myopathy: a systematic review of 100 cases. J Clin Rheumatol. 2017, 23:149-54. 10.1097\/RHU.0000000000000497","journal-title":"J Clin Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa150","article-title":"2019 vs. 2016 ESC\/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease","volume":"41","author":"Mortensen MB","year":"2020","unstructured":"Mortensen MB, Nordestgaard BG. 2019 vs. 2016 ESC\/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease. Eur Heart J. 2020, 41:3005-15. 10.1093\/eurheartj\/ehaa150","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5114\/reum.2018.79502","article-title":"Differential diagnosis of idiopathic inflammatory myopathies in adults - the first step when approaching a patient with muscle weakness","volume":"56","author":"Szcz\u0119sny P","year":"2018","unstructured":"Szcz\u0119sny P, \u015awierkocka K, Olesi\u0144ska M. Differential diagnosis of idiopathic inflammatory myopathies in adults - the first step when approaching a patient with muscle weakness. Reumatologia. 2018, 56:307-15. 10.5114\/reum.2018.79502","journal-title":"Reumatologia"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.687585","article-title":"Hydrophilic or lipophilic Statins?","volume":"8","author":"Climent E","year":"2021","unstructured":"Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or lipophilic Statins?. Front Cardiovasc Med. 2021, 8:687585. 10.3389\/fcvm.2021.687585","journal-title":"Front Cardiovasc Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.03.010","article-title":"Mechanisms of statin-associated skeletal muscle-associated symptoms","volume":"154","author":"Bouitbir J","year":"2020","unstructured":"Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Kr\u00e4henb\u00fchl S. Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res. 2020, 154:104201. 10.1016\/j.phrs.2019.03.010","journal-title":"Pharmacol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-021-00492-8","article-title":"Association between vitamin D and statin-related myopathy: a meta-analysis","volume":"22","author":"Hou Q","year":"2022","unstructured":"Hou Q, Pang C, Chen Y. Association between vitamin D and statin-related myopathy: a meta-analysis. Am J Cardiovasc Drugs. 2022, 22:183-93. 10.1007\/s40256-021-00492-8","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2589-z","article-title":"Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase","volume":"75","author":"Essers D","year":"2019","unstructured":"Essers D, Sch\u00e4ublin M, Kullak-Ublick GA, Weiler S. Statin-associated immune-mediated necrotizing myopathy: a retrospective analysis of individual case safety reports from VigiBase. Eur J Clin Pharmacol. 2019, 75:409-16. 10.1007\/s00228-018-2589-z","journal-title":"Eur J Clin Pharmacol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000131519.15067.1f","article-title":"Safety of statins: focus on clinical pharmacokinetics and drug interactions","volume":"109","author":"Bellosta S","year":"2004","unstructured":"Bellosta S, Paoletti R, Corsini A. Safety of statins: focus on clinical pharmacokinetics and drug interactions. Circulation. 2004, 109:III50-7. 10.1161\/01.CIR.0000131519.15067.1f","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mus.23854","article-title":"Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies","volume":"48","author":"Mohassel P","year":"2013","unstructured":"Mohassel P, Mammen AL. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies. Muscle Nerve. 2013, 48:477-83. 10.1002\/mus.23854","journal-title":"Muscle Nerve"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103468","article-title":"Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues","volume":"22","author":"Khoo T","year":"2023","unstructured":"Khoo T, Chinoy H. Anti-HMGCR immune-mediated necrotising myopathy: addressing the remaining issues. Autoimmun Rev. 2023, 22:103468. 10.1016\/j.autrev.2023.103468","journal-title":"Autoimmun Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-016-8867-x","article-title":"Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure","volume":"65","author":"Shovman O","year":"2017","unstructured":"Shovman O, Gilburd B, Chayat C, et al.. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Immunol Res. 2017, 65:276-81. 10.1007\/s12026-016-8867-x","journal-title":"Immunol Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23113","article-title":"Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with drb1*07:01 and severe myositis in juvenile myositis patients","volume":"69","author":"Kishi T","year":"2017","unstructured":"Kishi T, Rider LG, Pak K, et al.. Association of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies with drb1*07:01 and severe myositis in juvenile myositis patients. Arthritis Care Res (Hoboken). 2017, 69:1088-94. 10.1002\/acr.23113","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000975","article-title":"Update on muscle imaging in myositis","volume":"35","author":"Tan AL","year":"2023","unstructured":"Tan AL, Di Matteo A, Wakefield RJ, Biglands J. Update on muscle imaging in myositis. Curr Opin Rheumatol. 2023, 35:395-403. 10.1097\/BOR.0000000000000975","journal-title":"Curr Opin Rheumatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/343757-progressive-muscle-weakness-identifying-necrotizing-autoimmune-myopathy-as-a-rare-culprit","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T14:51:32Z","timestamp":1739803892000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/343757-progressive-muscle-weakness-identifying-necrotizing-autoimmune-myopathy-as-a-rare-culprit"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.79164","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}